BIOMAT Database Logo BIOMAT Database Logo

Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man. 1974

J Hunter, and W R Burnham, and L F Chasseaud, and W Down

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008297 Male Males
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D005260 Female Females
D005984 Glutethimide A hypnotic and sedative. Its use has been largely superseded by other drugs. Doriden,Noxiron
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000272 Adipates Derivatives of adipic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,6-carboxy terminated aliphatic structure. Adipic Acids,Hexanedioic Acids,Acids, Adipic,Acids, Hexanedioic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Hunter, and W R Burnham, and L F Chasseaud, and W Down
Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
March 1980, International journal of clinical pharmacology, therapy, and toxicology,
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
December 1979, The American journal of clinical nutrition,
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man.
December 1975, British journal of clinical pharmacology,
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
Urinary D-glucaric acid excretion and plasma antipyrine kinetics during enzyme induction.
June 1974, British journal of clinical pharmacology,
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
Overnight urine specimens for the determination of D-glucaric acid excretion in man.
August 1979, British journal of clinical pharmacology,
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
Excretion of D-glucaric acid and metabolism of salicylamide in man: the effect of phenobarbital-produced enzymatic induction.
January 1977, Polish journal of pharmacology and pharmacy,
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
CHANGES IN D-GLUCARIC ACID EXCRETION INDUCED BY STIMULATORS OF ASCORBIC ACID BIOSYNTHESIS.
December 1963, Biochimica et biophysica acta,
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
An evaluation of urinary D-glucaric acid excretion during acute hepatitis in man.
January 1978, The American journal of digestive diseases,
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
Valproate induces urinary D-glucaric acid excretion.
April 1981, Lancet (London, England),
J Hunter, and W R Burnham, and L F Chasseaud, and W Down
Urinary d-glucaric acid excretion as a measure of hepatic enzyme induction in man.
March 1971, Clinical science,
Copied contents to your clipboard!